KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hologic (HOLX) Asset Writedowns and Impairment (2019 - 2025)

Historic Asset Writedowns and Impairment for Hologic (HOLX) over the last 12 years, with Q3 2025 value amounting to $5.0 million.

  • Hologic's Asset Writedowns and Impairment changed N/A to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $225.9 million, marking a year-over-year increase of 40424.11%. This contributed to the annual value of $225.9 million for FY2025, which is 40424.11% up from last year.
  • Latest data reveals that Hologic reported Asset Writedowns and Impairment of $5.0 million as of Q3 2025.
  • In the past 5 years, Hologic's Asset Writedowns and Impairment ranged from a high of $220.9 million in Q1 2025 and a low of $4.3 million during Q4 2023
  • Its 4-year average for Asset Writedowns and Impairment is $70.5 million, with a median of $26.8 million in 2024.
  • Per our database at Business Quant, Hologic's Asset Writedowns and Impairment tumbled by 9266.99% in 2024 and then skyrocketed by 72425.37% in 2025.
  • Over the past 4 years, Hologic's Asset Writedowns and Impairment (Quarter) stood at $35.9 million in 2022, then crashed by 88.02% to $4.3 million in 2023, then surged by 218.6% to $13.7 million in 2024, then plummeted by 63.5% to $5.0 million in 2025.
  • Its Asset Writedowns and Impairment stands at $5.0 million for Q3 2025, versus $220.9 million for Q1 2025 and $13.7 million for Q2 2024.